Search Within

Marc Rosenblum

  1. "Survivorship Research"
Formats
  1. Journal Article (28)
  2. Meeting Abstract (14)
Groups
  1. Department of Pathology and Laboratory Medicine (42)
  2. Survivorship Research (42)
  3. Pediatrics, Department of (33)
  4. Neuro-Oncology Service (31)
  5. Radiology, Department of (16)
  6. Center for Hematologic Malignancies (14)

More Groups

People
  1. Ira Dunkel (27)
  2. Matthias Karajannis (9)
  3. Sofia Haque (9)
  4. Jonathan Finlay (8)
  5. Stephen Gilheeney (8)
  6. Tejus Bale (8)

More People

Years
  1. 2024 (3)
  2. 2023 (4)
  3. 2022 (3)
  4. 2021 (3)
  5. 2020 (2)
  6. 2019 (1)

More Years

Publications
  1. Pediatric Blood and Cancer (9)
  2. Neuro-Oncology (8)
  3. Journal of Clinical Oncology (6)
  4. Journal of Neuro-Oncology (4)
  5. Cancer Discovery (2)
  6. Pediatric Dermatology (2)

More Publications

Publishers
  1. Oxford University Press (9)
  2. Wiley Periodicals, Inc (9)
  3. American Society of Clinical Oncology (7)
  4. Springer (5)
  5. American Association for Cancer Research (3)
  6. Blackwell Scientific Publications (2)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Direct patient outreach in pediatric neurooncology to improve access to genomic profiling – The make-an-impact program
    Meeting Abstract

    Sait, S. F.; O'Donohue, T.; Hill, K.; Stockfish, E.; Giantini-Larsen, A.; Alano, T.; Bale, T.; Rosenblum, M.; Benhamida, J.; Dunkel, I.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Minimally-invasive molecular diagnosis of infiltrating brainstem gliomas through cerebrospinal fluid cell-free DNA sequencing
    Meeting Abstract

    Hill, K.; Giantini-Larsen, A.; Hickman, R. A.; Holle, B. M.; Ucpinar, B. A.; Alano, T.; Doe-Tetteh, S.; DiNapoli, S.; Riviere-Cazaux, C.; Burns, T. C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
    Journal Article

    Friedman, J. S.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Dogan, A.; Pulitzer, M.; Busam, K. J.; Francis, J. H.; Rampal, R. K.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT
    Journal Article

    McLaughlin, L. A.; Yildirim, O.; Rosenblum, M. K.; Imber, B. S.; Haseltine, J. M.; Zelefsky, M. J.; Schöder, H.; Morris, M. J.; Rafelson, W. M.; Krebs, S.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Karajannis, M.; Haque, S.; Pasquini, L.; Yildirim, O.; Rosenblum, M.; Benhamida, J. K.; Cheung, N. K.; Souweidane, M.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • A multinational series of 26 patients with mixed histiocytic neoplasms highlighting a diverse mutational landscape and superior efficacy of targeted therapies
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Ulaner, G. A.; Reddy, R.; Lacouture, M. E.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Radiation induced high grade gliomas: A single center experience
    Meeting Abstract

    Joshirao, M.; Sait, S. F.; Bouvier, N.; Hill, K.; Khakoo, Y.; Kramer, K.; Gilheeney, S.; Wolden, S.; Nolan, C.; Schaff, L.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Yabe, M.; Petrova-Drus, K.; Rosenblum, M.; Rotemberg, V.; Lacouture, M. E.; Rampal, R.; Francis, J.; Knoerzer, D.; Kreider, B.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Radiation induced high grade gliomas: A single center experience
    Meeting Abstract

    Joshirao, M.; Sait, S. F.; Bouvier, N.; Hill, K.; Khakoo, Y.; Kramer, K.; Gilheeney, S.; Wolden, S.; Nolan, C.; Schaff, L.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save